Part of the UT Health Science Center
The Cancer Therapy & Research Center is the answer for cancer
A Cancer Center designated by the National Cancer Institute
This is a study of pembrolizumab (KEYTRUDA) in combination of REOLYSIN (pelareorep) and chemotherapy in patients with advanced pancreatic cancer.
This study will evaluate the combination of REOLYSIN, chemotherapy and pembrolizumab. This study is intended to find the best dose to use in further studies.
To enroll or if you have questions about participation
Type of Cancer Treated